Ignite Creation Date:
2025-12-24 @ 12:06 PM
Ignite Modification Date:
2026-01-27 @ 4:57 AM
Study NCT ID:
NCT01015261
Status:
COMPLETED
Last Update Posted:
2010-11-22
First Post:
2009-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Allogenic Bone Marrow Transplantation (BMT) Compare With Cytoreduction and Chemotherapy in Acute Lymphoblastic Leukemia (ALL) Patients
Sponsor:
Tehran University of Medical Sciences
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HORCSCT-0903
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Mahdi Jalili MD / Hematology-Oncology and SCT Research Center
Old Organization:
Tehran University of Medical Sciences